UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The role of dose rate in radiation cancer risk: evaluating the effect of dose rate at the molecular, cellular and tissue levels using key events in critical pathways following exposure to low LET radiation

International journal of radiation biology, 2016-08, Vol.92 (8), p.405-426

2016

Volltextzugriff (PDF)

Introduction of the 42nd Lauriston S. Taylor Lecturer: Hans-Georg Menzel

Health physics (1958), 2019-02, Vol.116 (2), p.220-221

Julian Preston, R

2019

Volltextzugriff (PDF)

Cancer Risks Attributable to Low Doses of Ionizing Radiation: Assessing What We Really Know

Proceedings of the National Academy of Sciences - PNAS, 2003-11, Vol.100 (24), p.13761-13766

2003

Volltextzugriff (PDF)

Adverse outcome pathways, key events, and radiation risk assessment

International journal of radiation biology, 2021-06, Vol.97 (6), p.804-814

2021

Volltextzugriff (PDF)

Application of Key Events Analysis to Chemical Carcinogens and Noncarcinogens

Critical reviews in food science and nutrition, 2009-09, Vol.49 (8), p.690-707

2009

Volltextzugriff (PDF)

The use of mode of action information in risk assessment: Quantitative key events/dose-response framework for modeling the dose-response for key events

Critical reviews in toxicology, 2014-08, Vol.44 (S3), p.17-43

2014

Volltextzugriff (PDF)

Creating context for the use of DNA adduct data in cancer risk assessment: I. Data organization

Critical reviews in toxicology, 2009-09, Vol.39 (8), p.659-678

2009

Volltextzugriff (PDF)

Can radiation research impact the estimation of risk?

International journal of radiation biology, 2017-10, Vol.93 (10), p.1009-1014

Preston, R. Julian

2017

Volltextzugriff (PDF)

DNA-Reactive Carcinogens: Mode of Action and Human Cancer Hazard

Critical reviews in toxicology, 2005-10, Vol.35 (8-9), p.673-683

2005

Volltextzugriff (PDF)

Integrating basic radiobiological science and epidemiological studies: why and how

Health physics (1958), 2015-02, Vol.108 (2), p.125-130

Preston, R Julian

2015

Volltextzugriff (PDF)

Uncertainties in estimating health risks associated with exposure to ionising radiation

Journal of radiological protection, 2013-09, Vol.33 (3), p.573-588

2013

Volltextzugriff (PDF)

OBITUARY: Professor Krishnaswami Sankaranarayanan (1934–2022)

Journal of radiological protection, 2022-09, Vol.42 (3), p.35001

2022

Volltextzugriff (PDF)

A proposed framework for assessing risk from less-than-lifetime exposures to carcinogens

Critical reviews in toxicology, 2011-07, Vol.41 (6), p.507-544

2011

Volltextzugriff (PDF)

Systems Biology and Mode of Action Based Risk Assessment

Toxicological sciences, 2008-12, Vol.106 (2), p.312-318

2008

Volltextzugriff (PDF)

International organizations, risk assessment and research–Why, what and how

Mutation research, 2017-12, Vol.806, p.75-80

Preston, R. Julian

2017

Volltextzugriff (PDF)

The LNT risk model and radiological protection

Journal of radiological protection, 2023-12, Vol.43 (4), p.40201

2023

Volltextzugriff (PDF)

Recent Epidemiologic Studies and the Linear No-Threshold Model For Radiation Protection-Considerations Regarding NCRP Commentary 27

Health physics (1958), 2019-02, Vol.116 (2), p.235-246

2019

Volltextzugriff (PDF)

4-Aminobiphenyl and DNA Reactivity: Case Study Within the Context of the 2006 IPCS Human Relevance Framework for Analysis of a Cancer Mode of Action for Humans

Critical reviews in toxicology, 2006-11, Vol.36 (10), p.803-819

2006

Volltextzugriff (PDF)

Radiation adverse outcome pathways (AOPs) are on the horizon: advancing radiation protection through an international Horizon-Style exercise

International journal of radiation biology, 2022-12, Vol.98 (12), p.1763-1776

2022

Volltextzugriff (PDF)

DNA Reactivity as a Mode of Action and Its Relevance to Cancer Risk Assessment

Toxicologic pathology, 2013-02, Vol.41 (2), p.322-325

Preston, R. Julian

2013

Volltextzugriff (PDF)

Update on linear non-threshold dose-response model and implications for diagnostic radiology procedures

Health physics (1958), 2008-11, Vol.95 (5), p.541

Preston, R Julian

2008

Volltextzugriff (PDF)

Dose-response approaches for nuclear receptor-mediated modes of action for liver carcinogenicity: Results of a workshop

Critical reviews in toxicology, 2014-01, Vol.44 (1), p.50-63

2014

Volltextzugriff (PDF)

Response to Letter by Moghissi and Calderone

Health physics (1958), 2019-08, Vol.117 (2), p.224-225

2019

Volltextzugriff (PDF)

Epigenetic processes and cancer risk assessment

Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis, 2007-03, Vol.616 (1), p.7-10

Preston, R. Julian

2007

Volltextzugriff (PDF)

Quantitation of Molecular Endpoints for the Dose-Response Component of Cancer Risk Assessment

Toxicologic pathology, 2002-01, Vol.30 (1), p.112-116

Julian Preston, R.

2002

Volltextzugriff (PDF)

1 – 25 von 176

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(146)
Mit Volltextzugriff
(127)

Publikationsform

Sprache

Englisch
(176)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(119)
Life Sciences & Biomedicine
(112)
Humans
(91)
Biological And Medical Sciences
(65)
Toxicology
(55)
Animals
(52)
Medical Sciences
(43)
Male
(36)
Female
(33)
Risk Assessment
(30)
Genetics & Heredity
(28)
Fundamental And Applied Biological Sciences. Psychology
(25)
Environmental Sciences
(23)
Environmental Sciences & Ecology
(23)
Tumors
(22)
Chromosome Aberrations
(21)
Dose-Response Relationship, Drug
(21)
Carcinogens - Toxicity
(19)
Public, Environmental & Occupational Health
(18)
Radiology, Nuclear Medicine & Medical Imaging
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The role of dose rate in radiation cancer risk: evaluating the effect of dose rate at the molecular, cellular and tissue levels using key events in critical pathways following exposure to low LET radiation

Introduction of the 42nd Lauriston S. Taylor Lecturer: Hans-Georg Menzel

Cancer Risks Attributable to Low Doses of Ionizing Radiation: Assessing What We Really Know

Adverse outcome pathways, key events, and radiation risk assessment

Application of Key Events Analysis to Chemical Carcinogens and Noncarcinogens

The use of mode of action information in risk assessment: Quantitative key events/dose-response framework for modeling the dose-response for key events

Creating context for the use of DNA adduct data in cancer risk assessment: I. Data organization

Can radiation research impact the estimation of risk?

DNA-Reactive Carcinogens: Mode of Action and Human Cancer Hazard

Integrating basic radiobiological science and epidemiological studies: why and how

Uncertainties in estimating health risks associated with exposure to ionising radiation

OBITUARY: Professor Krishnaswami Sankaranarayanan (1934–2022)

A proposed framework for assessing risk from less-than-lifetime exposures to carcinogens

Systems Biology and Mode of Action Based Risk Assessment

International organizations, risk assessment and research–Why, what and how

The LNT risk model and radiological protection

Recent Epidemiologic Studies and the Linear No-Threshold Model For Radiation Protection-Considerations Regarding NCRP Commentary 27

4-Aminobiphenyl and DNA Reactivity: Case Study Within the Context of the 2006 IPCS Human Relevance Framework for Analysis of a Cancer Mode of Action for Humans

Radiation adverse outcome pathways (AOPs) are on the horizon: advancing radiation protection through an international Horizon-Style exercise

DNA Reactivity as a Mode of Action and Its Relevance to Cancer Risk Assessment

Update on linear non-threshold dose-response model and implications for diagnostic radiology procedures

Dose-response approaches for nuclear receptor-mediated modes of action for liver carcinogenicity: Results of a workshop

Response to Letter by Moghissi and Calderone

Epigenetic processes and cancer risk assessment

Quantitation of Molecular Endpoints for the Dose-Response Component of Cancer Risk Assessment

Suchergebnisse filtern